Real-world Evaluation of Tolerability, Safety and Efficacy of Rivastigmine Oral Solution in Patients with Mild to Moderate Alzheimer's Disease Dementia-Reference-Cited by-同舟云学术

Real-world Evaluation of Tolerability, Safety and Efficacy of Rivastigmine Oral Solution in Patients with Mild to Moderate Alzheimer's Disease Dementia

Published:2021-08-31 Issue:3 Volume:19 Page:459-469
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Hsieh Sun-Wung¹²³^ORCID,Chen Jui-Cheng⁴⁵⁶^ORCID,Chen Nai-Ching⁷⁸^ORCID,Jhang Kai-Ming⁹^ORCID,Wang Wenfu⁹¹⁰^ORCID,Yang Yuan-Han²³¹¹¹²¹³^ORCID

Affiliation:

1. Department of Neurology, Kaohsiung Municipal Siao-Gang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

2. Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

3. Neuroscience Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan

4. Department of Neurology, China Medical University Hsinchu Hospital, Taichung, Taiwan

5. Department of Neurology, China Medical University Hospital, Taichung, Taiwan

6. School of Medicine, China Medical University, Taichung, Taiwan

7. Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

8. Department of Neurology, Chang Gung University College of Medicine, Kaohsiung, Taiwan

9. Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan

10. Department of Holistic Wellness, Ming Dao University, Changhua, Taiwan

11. Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

12. Department of and Master’s Program in Neurology, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

13. Chinese Mentality Protection Association, Kaohsiung, Taiwan

Funder

Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan

Neuroscience Research Center, Kaohsiung Medical University Research Center Grant

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

https://pdf.medrang.co.kr/CPN2/2021/019/CPN2019-03-459.pdf

Reference51 articles.

1. Gauthier S. Advances in the pharmacotherapy of Alzheimer's disease. CMAJ 2002;166:616-623.

2. β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity

3. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association [published erratum appears in Am J Psychiatry 1997 Aug;154(8):1180]

4. Diagnosis and Treatment of Alzheimer Disease and Related Disorders

5. Practice parameter: Management of dementia (an evidence-based review) [RETIRED]

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Response of Iranian Alzheimer’s Patients to Rivastigmine Concerning Their Genotype for VDR rs11568820 and MTHFR C677T Variants: A Pharmacogenetic and Association Study;Journal of Molecular Neuroscience;2024-08-07

2. Development and Characterization of Rivastigmine Hydrogen Tartrate Elementary Osmotic Tablets;International Journal of Pharmaceutical Investigation;2023-12-27

3. Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives;Current Medicinal Chemistry;2023-10